Capital Flow Monitor · Sponsors · CIK 1574251
Mati Therapeutics Inc.
101 Colorado Street, AUSTIN, TX, 78701 · 512-720-1333
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$10.5M
Sold
$9.9M
% sold
93.8%
Investors
13
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-02 | D/A | 506(b) | $4.9M | $2.6M | 54.1% | 2 | EDGAR ↗ |
| 2025-10-08 | D ·current | 506(b) | $10.5M | $9.9M | 93.8% | 13 | EDGAR ↗ |
| 2025-09-23 | D | 506(b) | $2.2M | $2.2M | 100.0% | 1 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Robert Butchofsky — Executive Officer / Director, Austin, TX
-
Christopher Muller — Executive Officer / Director, Austin, TX
1 other raise
- Great Pacific Gold Corp. $4.8M of $8.4M · 57.3%
- Deepank Utkhede — Director, Austin, TX
- Joseph Tortorice III — Director, Austin, TX
- Cameron Nelson — Executive Officer, Austin, TX
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.